English Kevan, Erpelding Mercedes, Kaldas Sandra, Semoin Sabrine
Department of Surgery, St. George's University School of Medicine, Saint George, Grenada Email:
Department of Surgery, Ross University School of Medicine, Bridgetown, Barbados.
Qatar Med J. 2024 Feb 15;2024(1):7. doi: 10.5339/qmj.2024.7. eCollection 2024.
Anal carcinoma is a relatively uncommon tumor that accounts for less than 2% of large bowel malignancies and approximately 1-6% of anorectal tumors. Most anal cancers originate in the mucosa between the anorectal junction and the anal verge. Risk factors for anal carcinoma include human papillomavirus (HPV), immunosuppression, older age, female gender, and smoking. Approximately 85% of anal cancers are squamous cell carcinoma, and the pathophysiology is believed to be linked to HPV-related inflammation, leading to dysplasia and progression to cancer.
We present the case of a 65-year-old woman who sought medical attention at the emergency department (ED) due to rectal pain and concurrent rectal lesions persisting for the past three months. Before admission, she reported abdominal discomfort and constipation for 2-3 months, during which she took laxatives for relief. Laboratory findings in the ED were significant for anemia and leukocytosis, with all other values within normal limits. Blood tests, including antibodies for HPV and human immunodeficiency virus, were negative. A computed tomography scan of the abdomen and pelvis was largely unremarkable. On physical examination, perianal lesions with heaped-up edges were observed. A punch biopsy was subsequently performed, revealing squamous cell carcinoma (SCC). About three weeks following discharge, after one week of admission to the general medicine ward, the patient started chemoradiation therapy and reported some improvement in her symptoms. Seven weeks later, she was in remission.
Squamous cell carcinoma (SCC) of the anus, a rare disease entity, is often a slow and progressive malignancy. The length of time for patients to become symptomatic, in combination with its mimicking clinical presentation to common gastrointestinal tract diseases and its rarity, makes diagnosis challenging. Additionally, a patient lacking traditional risk factors for anal cancer, such as HPV and smoking, may further complicate diagnosis, treatment, and quality of life.
This case report emphasizes the pathogenesis and the similarities in clinical presentation of anal cancer to mild diseases, which may lead to a delay in diagnosis. Patients with anal carcinoma often delay seeking medical care, which is anecdotal in relation to the considerable overlap in symptoms of benign diseases such as hemorrhoids. Therefore, patients with "hemorrhoid" complaints, rectal bleeding, or rectal mass should warrant further physical examination and prompt referral to a gastroenterologist or a colorectal surgeon for additional evaluation.
肛管癌是一种相对罕见的肿瘤,占大肠恶性肿瘤的比例不到2%,约占肛门直肠肿瘤的1 - 6%。大多数肛管癌起源于肛管直肠交界处和肛缘之间的黏膜。肛管癌的危险因素包括人乳头瘤病毒(HPV)、免疫抑制、老年、女性性别和吸烟。约85%的肛管癌为鳞状细胞癌,其病理生理学被认为与HPV相关炎症有关,导致发育异常并进展为癌症。
我们报告一例65岁女性病例,她因直肠疼痛及持续三个月的直肠病变到急诊科就诊。入院前,她自述有2 - 3个月的腹部不适和便秘,期间服用泻药缓解症状。急诊科的实验室检查结果显示有贫血和白细胞增多,其他各项指标均在正常范围内。包括HPV抗体和人类免疫缺陷病毒抗体在内的血液检查均为阴性。腹部和盆腔的计算机断层扫描结果基本正常。体格检查时,发现肛周病变边缘隆起。随后进行了穿刺活检,结果显示为鳞状细胞癌(SCC)。出院约三周后,即入住普通内科病房一周后,患者开始接受放化疗,症状有所改善。七周后,病情缓解。
肛门鳞状细胞癌(SCC)是一种罕见的疾病实体,通常是一种缓慢进展的恶性肿瘤。患者出现症状的时间长度,加上其临床表现与常见胃肠道疾病相似且较为罕见,使得诊断具有挑战性。此外,缺乏肛管癌传统危险因素(如HPV和吸烟)的患者,可能会使诊断、治疗和生活质量进一步复杂化。
本病例报告强调了肛管癌的发病机制以及其临床表现与轻症疾病的相似性,这可能导致诊断延迟。肛管癌患者往往延迟就医,这与痔疮等良性疾病症状有相当大的重叠有关。因此,有“痔疮”主诉、直肠出血或直肠肿物的患者应接受进一步体格检查,并及时转诊至胃肠病学家或结直肠外科医生处进行进一步评估。